Source link : https://newshealth.biz/health-news/good-news-for-tofacitinib-in-recent-study-of-acute-severe-uc/
A head-to-head comparison of the JAK inhibitor drug tofacitinib and chimeric monoclonal antibody infliximab in the treatment of acute severe ulcerative colitis (ASUC) shows that, contrary to concerns, tofacitinib is not associated with worse postoperative complications and in fact may reduce the risk of the need for colectomy. “Tofacitinib has shown efficacy in managing ASUC, […]
The post Good News for Tofacitinib in Recent Study of Acute Severe UC first appeared on News Health.
—-
Author : News Health
Publish date : 2025-07-11 11:12:00
Copyright for syndicated content belongs to the linked Source.
—-
1 – 2 – 3 – 4 – 5 – 6 – 7 – 8